Targetted Therapy

Targeted Therapy

Targeted Therapy is a type of cancer treatment that uses drugs designed to "target" specific molecules—usually proteins—that tell cancer cells to grow, divide, and spread. Unlike traditional chemotherapy, which kills all rapidly dividing cells (including healthy ones like hair and gut lining), targeted therapy is more precise. It is considered the cornerstone of Precision Medicine, acting like a "smart bomb" that identifies and attacks cancer cells while sparing healthy tissue.

When You Should Consider Targeted Therapy

• Mutation-Positive Cancers: When genetic testing confirms your tumor has a specific "driver mutation" (like EGFR, ALK, or HER2).

• Resistance to Chemotherapy: If standard chemotherapy has stopped working, targeted drugs may bypass the resistance pathways.

• Chronic Management: When the goal is to manage cancer as a long-term condition with fewer systemic side effects than traditional chemo.

• Combination Treatment: Often used alongside chemotherapy or radiation to make the cancer cells more vulnerable to treatment.

• Specific Cancers: Standard of care for many cases of Stage IV lung cancer, breast cancer, melanoma, and certain leukemias.

How It Works (The Mechanisms)

• Blocking Growth Signals: Targeted drugs block the mutated receptors on a cancer cell's surface that are stuck in the "on" position, effectively cutting off the command to grow.

• Angiogenesis Inhibition: These drugs stop the tumor from growing its own blood vessels, effectively "starving" it of the nutrients it needs to expand.

• Apoptosis Induction: Healthy cells naturally "self-destruct" when damaged; targeted therapy can jumpstart this process in cancer cells that have learned to ignore it.

• Delivering Toxins: Some drugs, known as Antibody-Drug Conjugates (ADCs), act as delivery trucks, carrying chemotherapy or radiation directly to the cancer cell to minimize "collateral damage."

• Signal Transduction Interference: Small-molecule drugs enter the cell to disrupt the internal communication lines that allow cancer to spread.

[Image showing angiogenesis inhibition where a tumor is deprived of new blood vessel growth]

The Role of Biomarker Testing

• Foundation of Precision Medicine: Targeted therapy is not "one size fits all." It is only effective if your cancer possesses the specific target the drug was built for.

• Genetic Mapping: Before starting, a pathologist performs Next-Generation Sequencing (NGS) on a biopsy sample to identify mutations like BRAF, KRAS, or ROS1.

• The Match: If a mutation is present, the drug is used. If absent, the drug will not work and may cause unnecessary side effects.

• Liquid Biopsies (2026 Standard): In many cases, a simple blood test can now detect these mutations, sometimes avoiding the need for a painful repeat tissue biopsy.

• Re-testing: Because cancer can mutate over time, doctors may re-test the tumor if it starts growing again to find a "second-generation" target.

Types of Targeted Therapy Drugs

• Small-Molecule Drugs: These tiny molecules enter the cancer cell to target proteins inside. They are almost always taken as daily oral tablets. (Examples: Imatinib, Erlotinib).

• Monoclonal Antibodies: Larger molecules that attach to the outer surface of the cancer cell or the surrounding area. These are usually given via IV Infusion. (Examples: Trastuzumab, Bevacizumab).

• Bispecific Antibodies (2026 Standard): A newer class that attaches to two different targets at once—often one on the cancer cell and one on an immune cell—to bring the "killer" cells directly to the tumor.

• Agnostic Drugs: Treatments that target a specific mutation regardless of where in the body the cancer started (e.g., NTRK inhibitors).

[Image comparing small-molecule drugs entering a cell vs. monoclonal antibodies attaching to the surface]

Pre-Procedure Preparation

• Comprehensive Genomic Profiling (CGP): Ensure your tumor has been tested for the full range of actionable mutations before selecting a drug.

• Baseline Bloodwork: Liver and kidney function tests are critical, as these organs process targeted medications.

• Blood Pressure Check: Many targeted therapies (especially angiogenesis inhibitors) can cause sudden spikes in blood pressure.

• Skin Care Prep: Since skin rashes are a very common side effect, stock up on the specific alcohol-free, thick moisturizers recommended by your oncology team.

• Medication Review: Some targeted drugs interact poorly with common supplements (like St. John’s Wort) or acid-reflux medications.

Life During Targeted Therapy

• Daily Consistency: Unlike chemo cycles with rest periods, oral targeted therapy is usually taken every single day to keep the cancer suppressed.

• Managing "The Rash": Many patients develop an acne-like rash on the face and chest. While frustrating, this often indicates the drug is working effectively.

• Monitoring Blood Pressure: You may be asked to keep a daily log of your blood pressure at home.

• Diarrhea Management: Small-molecule inhibitors can cause frequent digestive upset; keeping a "bland diet" and having anti-diarrheal meds ready is helpful.

• Long-term Stability: Many patients live for years on targeted therapy, maintaining a high quality of life and continuing to work or travel.

Benefits of Targeted Therapy

• Highly Precise: Specifically attacks cancer cells, which often means no hair loss and less severe nausea compared to chemotherapy.

• Oral Convenience: Many forms are simple pills taken at home, reducing the need for hours spent in an infusion center.

• Effective Against "Un-chemo-able" Cancers: Some cancers that are resistant to traditional chemo respond dramatically to targeted drugs.

• Improved Survival: For many Stage IV patients, targeted therapy has turned a terminal diagnosis into a manageable chronic illness.

• 2026 Advancements: Modern drugs are now being designed to cross the "blood-brain barrier," effectively treating cancer that has spread to the brain.